MGO One Seven LLC Purchases 942 Shares of Stryker Co. (NYSE:SYK)

MGO One Seven LLC grew its position in shares of Stryker Co. (NYSE:SYK - Free Report) by 38.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,397 shares of the medical technology company's stock after acquiring an additional 942 shares during the quarter. MGO One Seven LLC's holdings in Stryker were worth $1,223,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC purchased a new stake in Stryker in the 4th quarter valued at about $25,000. Rakuten Securities Inc. increased its position in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after acquiring an additional 68 shares during the last quarter. Centricity Wealth Management LLC purchased a new position in Stryker in the fourth quarter worth $30,000. BankPlus Trust Department bought a new position in Stryker in the 4th quarter valued at $33,000. Finally, Activest Wealth Management purchased a new stake in shares of Stryker during the 4th quarter valued at $36,000. Institutional investors own 77.09% of the company's stock.

Wall Street Analyst Weigh In

SYK has been the subject of a number of research analyst reports. StockNews.com downgraded shares of Stryker from a "buy" rating to a "hold" rating in a report on Thursday, March 6th. Royal Bank of Canada lifted their price target on shares of Stryker from $425.00 to $435.00 and gave the stock an "outperform" rating in a report on Wednesday, January 29th. Truist Financial increased their price objective on Stryker from $409.00 to $413.00 and gave the company a "hold" rating in a report on Thursday, January 30th. The Goldman Sachs Group set a $422.00 target price on Stryker in a research note on Tuesday, March 4th. Finally, Citigroup reissued a "buy" rating and issued a $450.00 price objective on shares of Stryker in a report on Wednesday, February 26th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $423.53.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares of the company's stock, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares of the company's stock, valued at $5,705,827.65. The trade was a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.90% of the company's stock.

Stryker Stock Up 0.4 %

Shares of Stryker stock traded up $1.52 on Monday, reaching $366.58. The company's stock had a trading volume of 1,223,251 shares, compared to its average volume of 1,356,505. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The firm's fifty day simple moving average is $367.37 and its two-hundred day simple moving average is $373.51. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $139.92 billion, a price-to-earnings ratio of 47.24, a P/E/G ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period in the prior year, the business posted $3.46 earnings per share. Equities analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.92%. Stryker's payout ratio is presently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.